Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) Phenyl Glycol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111944774B reveals novel MLADH enzyme for high-purity (R)-PED production. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101407780B details a novel site-directed mutagenesis method for producing high-purity (R)-phenylethylene glycol, offering significant cost and supply chain advantages.
Patent CN101469318A enables high-purity (R)-phenylethylene glycol via dual-enzyme coupling, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101469318B details enzymatic synthesis achieving 100 percent e.e. purity. This report analyzes cost reduction in chiral chemical manufacturing and supply chain reliability for global buyers.
Patent CN104830704A details a recombinant Candida parapsilosis strain producing (R)-phenylethylene glycol with 99.9% ee. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN101230363B details a novel recombinant E. coli strain for asymmetric synthesis. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN104830744A details a novel SD-AS coupled enzyme method for (R)-phenylglycol. Achieves 100% e.e. and 99.9% yield, offering significant cost reduction and supply reliability for pharmaceutical manufacturing.